Schizophrenia Research
Volume 98, Issue 1 , Pages 29-39 , January 2008

Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment

  • Robert K. McClure

      Affiliations

    • University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina, United States
    • Corresponding Author InformationCorresponding author. UNC Department of Psychiatry, CB 7160, Room 247, Wing C, Chapel Hill, NC 27510-7160, United States. Tel.: +1 919 843 6629; fax: +1 919 966 4180.
    • ,
  • Khary Carew

      Affiliations

    • University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina, United States
    • ,
  • Stacy Greeter

      Affiliations

    • University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina, United States
    • ,
  • Emily Maushauer

      Affiliations

    • University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina, United States
    • ,
  • Grant Steen

      Affiliations

    • University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina, United States
    • ,
  • Daniel R. Weinberger

      Affiliations

    • Clinical Brain Disorders Branch, NIMH, Bethesda, Maryland, United States

Received 27 January 2007 ,Revised 7 May 2007 ,Accepted 11 May 2007.

References 

  1. Ananth H, Popescu I, Crightly HD, Good CD, Frackowiak RSJ, Dolan RJD. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized VBM. American Journal of Psychiatry. 2002;159:1497–1505
  2. Andersson C, Hamer RM, Lawler CP, Mailman RB, Lieberman JA. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2002;27:143–151
  3. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychological Reports. 1966;19:3–11
  4. Chakos M, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. American Journal of Psychiatry. 1994;151:1430–1436
  5. Chakos M, Lieberman JA, Alvir J, Bilder R, Ashtari M. Caudate nuclei volumes in schizophrenic treated with typical antipsychotics or clozapine. The Lancet. 1995;345:456–457
  6. Christensen J, Holcomb J, Garver DL. State-related changes in cerebral white matter may underlie psychosis exacerbation. Psychiatry Research. 2004;130:71–78
  7. Corson PW, Nopoulos P, Miller DD, Arndt S, Andreason NC. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. American Journal of Psychiatry. 1999;156
  8. Corson PW, Nopoulos P, Miller DD, Arndt S, Andreason NC. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. American Journal of Psychiatry. 1999;156
  9. Dazzan PMK, Orr KG, Hutchinson G, Chitnis X, Suckling J, et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain. 2004;127:143–153
  10. Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005;30:765–774
  11. DeLisi L, Dauphinas ID, Gershon ES. Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. Schizophrenia Bulletin. 1988;14:185–191
  12. Delisi LE, Hoff AL, Schwartz JE. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biological Psychiatry. 1991;129:159–175
  13. DeLisi L, Stritzke P, Riordan H, Holan V, Boccio A, Kushner M, et al. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biological Psychiatry. 1992;31:241–254
  14. DeLisi L, Hoff A, Neale C. Asymmetries in the superior temporal lobe in male and female first-episode schizophrenic patients: measures of the planum temporale and superior temporal gyrus by MRI. Schizophrenia Research. 1994;12:19–28
  15. DeLisi L, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biological Psychiatry. 1995;38:349–360
  16. DeLisi L, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent tothe onset of schizophrenia. Psychiatry Research. Neuroimaging. 1997;74:129–140
  17. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders-Administration Booklet. Washington, DC: American Psychiatric Press, Inc.; 1994;
  18. Garver DL, Holcomb JA, Christensen JD. Cerebral cortical gray expansion associated with two second-generation antipsychotics. Biological Psychiatry. 2005;58:62–66
  19. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage. 2002;15:870–878
  20. Gogtay N, Sporn A, Clasen LS, Nugent TF, Greenstein D, Nicolson R, et al. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Archives of General Psychiatry. 2004;61:17–22
  21. Good C, Johnsrude IS, Ashburner J, Henson RNA, Friston KJ, Frackowiak RSJ. A voxel-based morphometric study of ageing in 465 normal human adult brains. NeuroImage. 2001;14:21–36
  22. Gur R, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, et al. A follow-up magnetic resonance imaging study of schizophrenia. Archives of General Psychiatry. 1998;55:145–152
  23. Heitmiller DR, Nopoulos PC, Andreasen NC. Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent. Schizophrenia Research. 2004;66:137–142
  24. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry. 2003;60:585–594
  25. Hulshoff H, Schnack HG, Mandl RCW, van Haren NEM, Koning H, Collins L, et al. Focal gray matter density changes in schizophrenia. Archives of General Psychiatry. 2001;58:1118–1125
  26. James AC, James S, Smith DM, Javaloyes A. Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia. American Journal of Psychiatry. 2004;161:1023–1029
  27. Job D, Whalley HC, McConnell S, Glabus MF, Johnstone EC, Lawrie SM. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. NeuroImage. 2002;17:880–889
  28. Keshavan M, Bagwell WW, Haas GL, Sweeney JA, Schooler NR, Pettegrew JW. Changes in caudate volume with neuroleptic treatment. The Lancet. 1994;344:1434
  29. Keshavan MS, Rosenberg D, Sweeney JA, Pettegrew JW. Decreased caudate volume in neuroleptic-naive psychotic patients. American Journal of Psychiatry. 1998;155:774–778
  30. Kubicki M, Shenton ME, Salisbury DF, Hirayasu KK, Kikinis R, Jolesz FA, et al. Voxel-based morphometric analysis of gray matter in first-episode schizophrenia. NeuroImage. 2002;17:1711–1719
  31. Lancaster JL, Summerin JL, Rainey L, Freitas CS, Fox P, Lancaster JL, et al. The Talairach Daemon, a database server for Talairach Atlas Labels. NeuroImage. 1997;5:S633
  32. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping. 2000;10:120–131
  33. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, et al. An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. American Journal of Psychiatry. 2001;158:625–631
  34. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, et al. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. American Journal of Psychiatry. 2004;161:1829–1836
  35. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry. 2005;62:361–370
  36. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of FMRI data sets. NeuroImage. 2003;19:1233–1239
  37. Marenco S, Egan MF, Goldberg TE, Knable MB, McClure RK, Winterer G, et al. Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series. Schizophrenia Research. 2002;57:221–226
  38. Massana G, Salgado-Pineda P, Junque C, Perez M, Baeza I, Pons A, et al. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. Journal of Clinical Psychopharmacology. 2005;25:111–117
  39. Mathalon D, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men. Archives General Psychiatry. 2001;58:148–157
  40. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, et al. MRI anatomy of schizophrenia. Biological Psychiatry. 1999;45:1099–1119
  41. McClure R, Phillips I, Jazayerli J, Barnett A, Coppola R, Weinberger DR. Regional change in brain morphometry in schizophrenia associeted with antipsychotic treatment. Psychiatry Research. 2006;148(2–3):121–132
  42. McCormick L, Decker L, Nopoulos P, Ho BC, Andreasen N. Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia. Schizophrenia Research. 2005;80:73–84
  43. Mechelli A, Price CJ, Friston KJ, Ashburner J. Voxel-based morphometry of the human brain: methods and applications. Current Medical Imaging Reviews. 2005;I:1–9
  44. Molina V, Reig S, Sanz J, Palomo T, Benito C, Sanchez J, et al. Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophrenia Research. 2005;80:61–71
  45. Nopoulos P, Ho BC, Pressler M, McCormick L, Andreason NC. Longitudinal assessment of the effects of neuroleptic medications on global cerebral measures in subjects with schizophrenia. In: Abstracts of the 20th International Conference on Schizophrenia Research. Savannah, GA. 2005;
  46. Oldfield RC. The assessment and analysis of handedness: the Edinburg inventory. Neuropsychologia. 1971;9:97–113
  47. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. The Lancet. 2002;361:281–288
  48. Pressler M, Nopoulos P, Ho BC, Andreasen NC. Insular cortex abnormalities in schizophrenia: relationship to symptoms and typical neuroleptic exposure. Biological Psychiatry. 2005;57:394–398
  49. Scheepers F, Gispen de Wied CC, Hulshoff HE, et al. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with neuroleptics. Neuropsychopharmacology. 2001;24:47–54
  50. Shihabuddin L, Buschbaum MS, Hazlett EA, Haznedar MM, Harvey PD, Newman A. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Archives of General Psychiatry. 1998;55:235–243
  51. Sowell E, Levitt J, Thompson PM, Holmes CJ, Blanton RE, Kornsand DS, et al. Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. American Journal of Psychiatry. 2000;157:1475–1484
  52. Strungas S, Christensen JD, Holcomb JM, Garver DL. State-related thalamic changes during antipsychotic treatment in schizophrenia: preliminary observations. Psychiatry Research. 2003;124:121–124
  53. Styner M, Lieberman JA, McClure RK, Weinberger DR, Jones DW, Gerig G. Morphometric analysis of lateral ventricles in schizophrenia and healthy controls regarding genetic and disease-specific factors. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:4872–4877
  54. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical Publishers; 1988;
  55. Tamagaki C, Sedvall GC, Jonsson EG, Okugawa G, Hall H, Pauli S, et al. Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. American Journal of Psychiatry. 2005;162:2315–2321
  56. Tauscher-Wisniewski S, Tauscher J, Christensen BK, Mikulis DJ, Zipursky RB. Volumetric MRI measurement of caudate nuclei in antipsychotic-naive patients suffering from a first episode of psychosis. Journal of Psychiatric Research. 2005;39:365–370
  57. Thompson P, Vidal Christine, Giedd JN, Gochman P, Blumenthal J, Nicolson R, et al. Mapping Adolescent Brain Change Reveals Dynamic Wave of Accellerated Gray Matter Loss in Very Early-onset Schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:11650–11655
  58. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Archives of General Psychiatry. 2002;59:553–558
  59. Wilke M, Kaufmann C, Grabner A, Putz B, Wettter TC, Auer DP. Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study. NeuroImage. 2001;13:814–824
  60. Wilkinson GS. WRAT-3: Wide Range Achievement Test. Wide Range, Inc.; 1993;
  61. Wright I, Ellison ZR, Sharma T, Friston KJ, Murray RM, MacGuire PK. Mapping of grey matter changes in schizophrenia. Schizophrenia Research. 1999;35:1–14
  62. Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, Macguire PK. Mapping of grey matter changes in schizophrenia. Schizophrenia Research. 1999;35:1–19
  63. Yushkevich PA, Piven J, Cody Hazlett H, Gimpel Smith R, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage. 2006;31:1116–1128

PII: S0920-9964(07)00224-1

doi: 10.1016/j.schres.2007.05.012

Schizophrenia Research
Volume 98, Issue 1 , Pages 29-39 , January 2008

Article Tools

* Image Usage & Resolution